日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic Diagnosis and Discovery Enabled by Large Language Models

大型语言模型助力基因诊断与发现

Tu, Tao; Saab, Khaled; Liu, Weida; Fang, Zhouqing; Cheng, Zhuanfen; Spasic, Svetolik; Djurisic, Maja; Mohri, Hiroaki; Ren, Wenlong; Palepu, Anil; Gottweis, Juraj; Karthikesalingam, Alan; Kulkarni, Kavita; Pawlosky, Annalisa; Bonner, Devon; Kravets, Elijah; Marwaha, Shruti; Mendez, Hector R; Wheeler, Matthew T; Bernstein, Jonathan A; Tsai, Cheng-Yu; Wu, Chen-Chi; Stankovic, Konstantina M; Natarajan, Vivek; Peltz, Gary

Multimodal phenotyping of ARDS: design and preliminary insights from the prospective BIOWARE cohort for precision critical management

ARDS的多模态表型分析:前瞻性BIOWARE队列研究的设计和初步见解,旨在实现精准重症监护。

Tan, Ziqi; Liu, Weida; Zhang, Song; Yang, Mei; Yue, Chaofu; Huang, Xian; Zhao, Keyi; Niu, Zuxi; Wang, Yongjie; Yu, Xin; Yu, Xiangyou; Yang, Chunbo; Ma, Siqing; Sun, Qiang; Zhu, Zhiqiang; Yang, Min; Wang, Fang; Zhang, Shulin; Su, Longxiang; Yang, Yingying; Wang, Qianlin; Long, Yun

Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons

Xeligekimab 与其他 IL-17A 抑制剂治疗中国中重度斑块状银屑病患者的疗效和安全性比较:一项匹配调整的间接比较研究

Ding, Yangfeng; Liu, Weida

A national biobank framework for rare diseases: Standardized infrastructure and cross-institutional collaboration accelerating translational innovation in China

国家罕见病生物样本库框架:标准化基础设施和跨机构合作加速中国转化创新

Liu, Weida; Jin, Ye; Zhang, Yaran; Wang, Anqi; Chen, Yiying; Li, Fangyuan; Zhao, Kun; He, Ruirui; Guo, Dan; Zhang, Shuyang

A Novel Hyphal Suspension Approach for MIC Testing of Mould Fungi

一种用于霉菌MIC测试的新型菌丝悬浮液方法

Zheng, Hailin; Li, Dongmei; Ge, Naicen; Mei, Huan; Li, Xiaofang; Liu, Weida

PDE4C stabilized by ELAVL1 promotes lymph node metastasis in papillary thyroid cancer.

ELAVL1 稳定的 PDE4C 促进乳头状甲状腺癌的淋巴结转移。

Cui Tingting, Zhang Ying, Li Wanwan, Zhang Danzhen, Liu Weida, Gong Haiying

Functional Complete Revascularization as Determined by an Optimized Scoring System After Revascularization: A Post Hoc Analysis from Multi-Center PANDA III Trial

采用优化评分系统确定的功能性完全血运重建:来自多中心 PANDA III 试验的事后分析

Zhang, Rui; Wu, Shaoyu; Liu, Qianqian; Guan, Changdong; Wang, Hao-Yu; Yuan, Sheng; Xie, Lihua; Huang, Yunfei; Qiao, Zheng; Liu, Weida; Fu, Rui; Feng, Lei; Zhu, Chenggang; Song, Lei; Yin, Dong; Dou, Kefei

Treatment strategies for patients with ischemic mitral regurgitation: a systematic review and meta-analysis

缺血性二尖瓣反流患者的治疗策略:系统评价和荟萃分析

Li, Qi; Liang, Meiling; Gao, Mingyou; Liu, Weida; Bie, Dongyun; Luo, Xinlin

Long-term exposure to outdoor fine particulate and physical activity with mortality and cardiovascular events: an analysis of the Prospective Urban Rural Epidemiology (PURE)-China cohort study

长期暴露于室外细颗粒物和身体活动与死亡率和心血管事件的关系:一项基于前瞻性城乡流行病学(PURE)-中国队列研究的分析

Hao, Jun; Liu, Zhiguang; Hu, Bo; Wang, Duolao; Rangarajan, Sumathy; Wang, Yang; Wang, Chuangshi; Tse, Lap Ah; Liu, Weida; Li, Sidong; Yan, Minghai; Cai, Qiujing; Yusuf, Salim; Li, Wei

Genomic epidemiology and antifungal resistance of emerging Trichophyton indotineae in China

中国新发印度毛癣菌的基因组流行病学及抗真菌耐药性

Xie, Wenting; Liang, Guanzhao; Kong, Xue; Tsui, Clement K M; She, Xiaodong; Liu, Weida; Li, Xiaofang